US2023051702A1PendingUtilityA1
Compositions for prevention and treatment of symptoms associated with alcohol consumption
Est. expiryFeb 22, 2039(~12.6 yrs left)· nominal 20-yr term from priority
Inventors:Monir M. Elias
A61K 31/352A61K 31/7034A61K 31/351A61K 31/198A61K 36/33A61K 9/0053A61K 36/67A61K 45/06A61K 9/0019A61K 36/9066A61K 36/28A61K 36/9068A61K 36/906A23L 2/395A61K 31/366A23V 2200/334A23L 2/52
62
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A composition for mitigating, treating, and/or preventing symptoms associated with veisalgia. In one embodiment the composition comprises one or more ingredients selected from the group consisting of: dihydromyricetin, N-acetyl cysteine, salicin, quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, monk fruit, turmeric, curcumin, ginger root, and black pepper extract. A method for treating symptoms associated with veisalgia is also described. In one embodiment, the composition is administered in liquid or pill form.
Claims
exact text as granted — not AI-modifiedI claim:
1 . A composition comprising dihydromyricetin, N-acetyl cysteine, and salicin.
2 . The composition of claim 1 further comprising at least one of the ingredients selected from the group consisting of: quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, turmeric, curcumin, milk thistle, monk fruit, hydroxypropyl-beta cyclodextrin, ginger root, and black pepper extract.
3 . The composition of claim 1 , wherein the composition is integrated into a liquid.
4 . The composition of claim 1 , wherein the composition is integrated into a capsule, tablet, chewable tablet, or pill.
5 . The composition of claim 1 , wherein the composition is in powder or liquid form and is readily integratable into food or drink.
6 . A method for treating symptoms associated with veisalgia comprising:
administering, to a patient, a composition comprising dihydromyricetin, N-acetyl cysteine, and salicin.
7 . The method of claim 6 , wherein the composition further comprises quercetin, bromelain, opuntia, potassium, sodium, magnesium, B-vitamins, vitamin C, taurine, caffeine, turmeric, curcumin, milk thistle, monk fruit, hydroxypropyl-beta cyclodextrin, ginger root, or black pepper extract, or a combination thereof.
8 . The method of claim 6 , wherein the composition is integrated into a liquid.
9 . The method of claim 6 , wherein the composition is integrated into a capsule, tablet, chewable tablet, or pill.
10 . The method of claim 6 , wherein the composition is administered via food or drink.
11 . The method of claim 6 , wherein the composition is administered by injection intravenously, intramuscularly, intrathecally, or subcutaneously; sublingually or buccally; rectally or vaginally; placed in the eye by the ocular route or the ear by the otic route; nasally; inhalation or by nebulization; applied to the skin cutaneous for a local topical or body wide systemic effect; or delivered through the skin by patch transdermally.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.